Incontinence News and Research

Latest Incontinence News and Research

Vaginal hysterectomies better than abdominal hysterectomies

A review of recent studies concludes that surgeons should perform vaginal rather than abdominal hysterectomies whenever possible in order to cut down on complications and the length of hospital stays.

24 Jan 2005

Clinical trial planned for stem cell treatment for stress urinary incontinence

ITL Laboratories, L.L.C. ("ITL") is planning a clinical trial to determine the effectiveness of a stem cell treatment for stress urinary incontinence. A recent clinical trial by Austrian researchers has demonstrated the potential usefulness of expanded muscle stem cell injections in the treatment of urinary incontinence.

24 Jan 2005

Higher risk of kidney infection among women with a history of incontinence and diabetes

Researchers at Seattle-based Group Health Cooperative and the University of Washington (UW) report that some of the same factors that put women at risk for simple, lower urinary tract infections (UTIs) - as well as some unexpected factors - also make them susceptible to more serious kidney infections.

4 Jan 2005

FDA approves Enablex for the treatment of overactive bladder

Novartis Pharmaceuticals Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved Enablex® (darifenacin) extended-release tablets (7.5mg and 15mg) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.

22 Dec 2004

10 to 20 million people in the United States have chronic kidney disease but most don’t know it

10 to 20 million people in the United States have chronic kidney disease but most don’t know it, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health, the National Institute of Diabetes and Digestive and Kidney Diseases and the National Center for Health Statistics.

19 Dec 2004

Detrol LA significantly reduces symptoms of overactive bladder

Pfizer today announced results of a comprehensive six-year review of efficacy and safety data for Detrol LA (tolterodine tartrate extended release capsules) indicating that Detrol LA significantly reduces symptoms of overactive bladder (OAB) with a low occurrence of side effects, and should be considered first-line therapy.

13 Dec 2004

Researchers are successfully treating incontinent women with the patient's own muscle-derived stem cells

Austrian researchers are successfully treating incontinent women with the patient's own muscle-derived stem cells. The findings of the first clinical study of its kind were presented today at the annual meeting of the Radiological Society of North America (RSNA).

29 Nov 2004

FDA approves Vesicare (solifenacin succinate) for the treatment of overactive bladder

Vesicare (solifenacin succinate) has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of overactive bladder (OAB) with symptoms of urgency, frequency, and urge incontinence.

23 Nov 2004

Urinary incontinence and abdominal pain are key symptoms of ovarian cancer

Results from an Olmsted Medical Center and Mayo Clinic study analyzing symptoms recorded in the medical records of ovarian cancer patients suggest ovarian cancer, long considered asymptomatic until late-stage cancer develops, does in fact have early symptoms, including urinary incontinence and abdominal pain.

18 Nov 2004

Urinary incontinence is passed down from mother to daughter

New research from the University of Bergen (UiB), Norway, shows that a woman who’s mother has urinary incontinence has a 30 percent greater chance for incontinence herself.

4 Nov 2004

Study clearly showed the benefit of weight loss in terms of pain, function and quality of life

Over 18 months, researchers at University Hospitals of Cleveland and Case Western Reserve University studied the frequency and prevalence of musculoskeletal (MSK) complaints in obese patients before and after undergoing gastric bypass surgery.

21 Oct 2004

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

The antidepressant Cymbalta (duloxetine HCl), a dual-reuptake inhibitor of serotonin and norepinephrine, 60 mg once or twice daily, significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression, according to 12-week data presented at the annual meeting of the American College of Rheumatology.

18 Oct 2004

Researchers make House of Commons focus on school toilets

Newcastle University researchers have played a key part in a national campaign to improve school toilets which is being launched at the House of Commons.

13 Oct 2004

Americans are as afraid of becoming an Alzheimer caregiver as they are of getting the disease

Americans are as afraid of becoming an Alzheimer caregiver as they are of getting the disease itself according to a new Omnibus survey of more than 1,000 adults released today by the Alzheimer’s Association.

5 Oct 2004

Episiotomy does not reduce the risk of injury to infants during a complicated birth

A new study from Johns Hopkins suggests that routine widening of the vagina, a procedure known as an episiotomy, does not reduce the risk of injury to infants during a complicated birth, such as when a baby's shoulders are stuck in the birth canal after the head is already out.

4 Oct 2004

Prostate cancer treatment leads to declines in sexual and urinary function

Treatment for prostate cancer leads to significant five-year declines in sexual and urinary function, according to a new study. However, general and other specific health-related quality of life factors, such as bowel function, are not affected.

27 Sep 2004

A low salt diet can be extremely dangerous for elderly people

Professor Füsgen presented his findings at the European Geriatrics Congress in Vienna, which ended yesterday (September 19). They show that the symptoms of hyponatraemia (low sodium level in the blood), which are tiredness, difficulty in concentrating and loss of balance, can develop into confusion and even coma if left untreated.

20 Sep 2004

European positive for Cymbalta and Xeristar

Eli Lilly and Company and Boehringer Ingelheim have announced that the Committee for Medicinal Products in Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion recommending approval of duloxetine for the treatment of major depressive episodes.

20 Sep 2004

Yentreve available in Europe for treatment of stress urinary incontinence

Yentreve (duloxetine hydrochloride) is now available in certain European countries, giving women suffering from moderate to severe stress urinary incontinence (SUI) a pharmaceutical treatment option for the first time.

13 Sep 2004

Cymbalta approved for diabetic peripheral neuropathy pain

The U.S. Food and Drug Administration has approved Eli Lilly's Cymbalta, a balanced and potent serotonin and norepinephrine reuptake inhibitor. Cymbalta is the first and only FDA-approved treatment for pain caused by diabetic peripheral neuropathy.

8 Sep 2004

Incontinence News and Research

Latest Incontinence News and Research

Vaginal hysterectomies better than abdominal hysterectomies

Clinical trial planned for stem cell treatment for stress urinary incontinence

Higher risk of kidney infection among women with a history of incontinence and diabetes

FDA approves Enablex for the treatment of overactive bladder

10 to 20 million people in the United States have chronic kidney disease but most don’t know it

Detrol LA significantly reduces symptoms of overactive bladder

Researchers are successfully treating incontinent women with the patient's own muscle-derived stem cells

FDA approves Vesicare (solifenacin succinate) for the treatment of overactive bladder

Urinary incontinence and abdominal pain are key symptoms of ovarian cancer

Urinary incontinence is passed down from mother to daughter

Study clearly showed the benefit of weight loss in terms of pain, function and quality of life

Cymbalta significantly reduced pain in more than half of women treated for fibromyalgia, with and without major depression

Researchers make House of Commons focus on school toilets

Americans are as afraid of becoming an Alzheimer caregiver as they are of getting the disease

Episiotomy does not reduce the risk of injury to infants during a complicated birth

Prostate cancer treatment leads to declines in sexual and urinary function

A low salt diet can be extremely dangerous for elderly people

European positive for Cymbalta and Xeristar

Yentreve available in Europe for treatment of stress urinary incontinence

Cymbalta approved for diabetic peripheral neuropathy pain

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Incontinence News and Research

Latest Incontinence News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in